Settings

Sidenav Mini

Light/Dark

Thursday June 30th 2022 Morning Stock Newsletter

🌟Goooooooood morning Team and Happy Money Thursday🌟 

WELCOME BACK to the WORLD’S BEST Trading Chatroom! I hope you all had a wonderful evening and that you are ready for today’s trading session. 

The market has been a little off this week as we have seen pretty choppy/inconsistent market conditions. This is a part of trading and we cannot expect the market to always be on fire. We simply have to assess and adapt to take advantage of what we have!

Everyone is doing fantastic so keep up the amazing work and lets attack this day and end this month on a STRONG note!!!

Live Stream is now up and Live Trade Commentary will begin at 8:50AM. πŸš€ πŸ‘ πŸ“ˆ πŸ”₯

Get πŸ”₯ FIRED πŸ”₯up team because we are hitting it hard today.


STOCKS WITH NEWS

Yesterdays top gainers $STRO $CRNT $DBTX $SBEV

Stock futures fall more than 1% as S&P 500 tracks for worst first half of the year since 1970 https://www.cnbc.com/2022/06/29/stock-market-futures-open-to-close-news.html

$CRM – Salesforce co-CEO Marc Benioff sold $53M in common stock

$ASPN – Aspen Aerogels’ Shares Up 56% Following Decision Not to Proceed With Concurrent Public Offerings

$REVB – Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.

$MARK – Robert Gatchell Joins Remark Holdings, Inc. as Senior Executive Vice President of Operations

$RNLX – Press Release: Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022

$MARK – Robert Gatchell Joins Remark Holdings, Inc. as Senior Executive Vice President of Operations

$ADAG – Update: Adagene Jumps 10% After Board Authorizes Share Buyback Program

My top stocks for the day

$REVBΒ is our #1 stock at this time. Currently up over 100% here in pre-market. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis. We are currently trying to break the DT and if we do we can see our next leg up to $1.75-$1.95

$NRSN – NeuroSense Therapeutics Reports Preliminary Results From Novel Alzheimer’s Biomarker Study; Says ‘Biomarkers show the potential of NeuroSense’s combination drug CogniC to treat Alzheimer’s disease’


PRE MARKET GAPPERS


PRIOR DAY TOP GAINERS


Earnings this Week